Osteoporosis, a treatment with few options, may have one more

17 Aug 2016


The results of a new promising drug for osteoporosis were published Tuesday in JAMA. The trial compared a new drug, abaloparatide, with a placebo and with the only other bone-building drug on the market, Eli Lilly’s Forteo.

New York Times


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story